Search Results - G.W. Prager
- Showing 1 - 3 results of 3
-
1
Long-term survival in patients with pancreatic cancer treated with second-line liposomal irinotecan plus 5-fluorouracil/leucovorin: observations from Korea, Italy, and Germany by S. Lonardi, K. Potthoff, L. Procaccio, C. Yoo, T. Macarulla, F. Hedouin-Biville, G.W. Prager
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article -
2
Managing adverse events in patients with metastatic colorectal cancer receiving trifluridine/tipiracil in combination with bevacizumab by M. Fakih, F. Ciardiello, G.W. Prager, E. Élez, E. Calleja, N. Caussé-Amellal, J. Taieb, E. Van Cutsem
Published in ESMO Gastrointestinal Oncology (2025-09-01)Get full text
Article -
3
Association between neutropenia and efficacy in patients with refractory mCRC receiving trifluridine/tipiracil + bevacizumab: post hoc analysis of the SUNLIGHT trial by G.W. Prager, E. Elez, M. Fakih, F. Ciardiello, E. Van Cutsem, L. Roby, W. Yao, E. Choucair, J. Taieb
Published in ESMO Gastrointestinal Oncology (2025-12-01)Get full text
Article
